SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

Right Now

+/-
-0.4
%
-2,68%
Latest
14.5
High
14.9
Low
14.5
Volume
5 185
Turnover (SEK)
76 163
Value (MSEK)
227,2

Board

CEO

  • Fredrik Herslow

Chairman Of The Board

  • Catharina Svanborg

Board

  • Björn Kettilsson Wullt
  • Carl-Johan Wachtmeister
  • Helena Lomberg

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 50,57 77,00 2019-11-08
FV Group AB 7,15 3,33 2019-09-30
Fredrik Herslow 4,40 2,05 2019-09-30
Jan Zetterberg 3,62 1,68 2019-09-30
Understödsföreningen Prometheus Pension 3,62 1,68 2019-09-30
Avanza Pension 2,73 1,27 2019-09-30
Frantek Invest AB 2,06 0,96 2019-09-30
Helena Lomberg 1,70 0,79 2019-09-30
Nordnet Pensionsförsäkring 1,54 0,72 2019-09-30
Björn Wullt 0,74 0,35 2019-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-02-20 Delårsrapport 2020-Q2

  • 2020-05-20 Delårsrapport 2020-Q3

  • 2020-08-27 Bokslutskommuniké 2020